Viridian Therapeutics, Inc.\DE (VRDN) — Revenue

Annual figures by fiscal year, from SEC filings.

2017: $4.00M2018: $8.39M2019: $4.46M2020: $1.05M2021: $2.96M2022: $1.77M2023: $314.0K2024: $302.0K2025: $70.85M$70.85M
2017Revenue (USD)2025
Fiscal YearRevenueChange YoY
2025$70.85M+23359.9%
2024$302.0K-3.8%
2023$314.0K-82.3%
2022$1.77M-40.2%
2021$2.96M+182.2%
2020$1.05M-76.5%
2019$4.46M-46.8%
2018$8.39M+109.5%
2017$4.00M